Paul Talmo is CTO at TELA Bio, Inc. (TELA). They have made 1 open-market trade across 1 company since 2024, most recently 2026-02-23.
CIK 0001899089
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $50K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TELA | 173,436 | $151K |
Shares reported on the most recent Form 4, priced at the 2026-02-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TELA | BUY | 2024-10-24 | 2024-10-24 | $2.25 | $50K | +5.4% | +6.1% | -3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.